JP6064156B2 - Deep body temperature raising agent - Google Patents

Deep body temperature raising agent Download PDF

Info

Publication number
JP6064156B2
JP6064156B2 JP2012154967A JP2012154967A JP6064156B2 JP 6064156 B2 JP6064156 B2 JP 6064156B2 JP 2012154967 A JP2012154967 A JP 2012154967A JP 2012154967 A JP2012154967 A JP 2012154967A JP 6064156 B2 JP6064156 B2 JP 6064156B2
Authority
JP
Japan
Prior art keywords
body temperature
black ginger
administration
extract
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012154967A
Other languages
Japanese (ja)
Other versions
JP2014015430A (en
Inventor
仁人 鍔田
仁人 鍔田
寛 友澤
寛 友澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Shinyaku Co Ltd
Original Assignee
Toyo Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Shinyaku Co Ltd filed Critical Toyo Shinyaku Co Ltd
Priority to JP2012154967A priority Critical patent/JP6064156B2/en
Publication of JP2014015430A publication Critical patent/JP2014015430A/en
Application granted granted Critical
Publication of JP6064156B2 publication Critical patent/JP6064156B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)

Description

本発明は、深部体温を上昇する剤に関する。   The present invention relates to an agent for increasing deep body temperature.

生体の体温は、身体深部の温度をあらわす深部体温と、体表面の温度をあらわす体表面温の二つに大別することができる。   The body temperature of a living body can be broadly divided into a deep body temperature that represents the temperature of the deep body and a body surface temperature that represents the temperature of the body surface.

体内外の温度が上昇すると、発汗や皮膚血管拡張などによって体内の熱を体外に放散し、逆に、体内外の温度が低下すると、皮膚血管が収縮したり、ふるえることによって熱を産生する。したがって、体表面温は、環境等の影響を受けて変化しやすい。これに対し、深部体温は生体の様々な生理反応が正常に機能するための基盤的な役目を担っており、ホメオスタシスの働きにより恒常性が維持されている。一方で、深部体温は、昼間高く夜には低下するという概日リズムも有する。   When the temperature inside and outside the body rises, heat inside the body is dissipated outside the body due to sweating or skin vasodilation, and conversely, when the temperature inside and outside the body falls, the skin blood vessels contract or shake to produce heat. Therefore, the body surface temperature is likely to change under the influence of the environment and the like. In contrast, deep body temperature plays a fundamental role in the normal functioning of various physiological responses in the living body, and homeostasis maintains homeostasis. On the other hand, deep body temperature also has a circadian rhythm in which it rises during the day and falls at night.

通常、人間の正常な体温は36〜37℃であり、この体温であれば免疫機能が活発に働き、健康を維持することができる。しかしながら、近年、喫煙、過度のストレス、運動不足、睡眠不足、無理なダイエット、冷房などの影響から、低体温症の人も増加している。体温が低下すると、代謝機能が低下し、自覚症状としては冷えを感じ、その他、下肢の浮腫、体の倦怠感などが現れてくる。一般に、平均体温が1℃下がると、免疫力は約37%下がるといわれている。反対に、平均体温が1℃上がると、免疫力は約60%活性化するといわれている。   Usually, the normal human body temperature is 36-37 ° C. With this body temperature, the immune function works actively and health can be maintained. However, in recent years, the number of people with hypothermia has also increased due to the effects of smoking, excessive stress, lack of exercise, lack of sleep, unreasonable diet, and cooling. When the body temperature decreases, metabolic function decreases, and the subjective symptoms are cold, and lower limb edema, body malaise, etc. appear. In general, it is said that when the average body temperature decreases by 1 ° C., the immunity decreases by about 37%. On the other hand, it is said that when the average body temperature increases by 1 ° C., the immunity is activated about 60%.

なお、一般的に、冷え性とは「手足や腰などがいつも冷たく感じる症状。また、その体質。」のことであり、自律神経の乱れ、ホルモンのアンバランス、低血圧、貧血により、主に体表面温度の調整が不調となることであるが、ここでいう「低体温症」や「冷え」とは現象が異なり、また、その対処法も異なる。   In general, coldness refers to “a symptom that the limbs and hips always feel cold. And the constitution.” It is mainly due to autonomic disturbance, hormonal imbalance, hypotension, and anemia. The adjustment of the surface temperature is unsatisfactory, but the phenomenon is different from “hypothermia” and “cold” here, and the countermeasures are also different.

従来、深部体温を上昇して、免疫機能を改善させるため、運動の励行、マッサージや食事の改善、漢方薬の摂取等がよく試みられてきたが、副作用がなく、かつ、簡便に経口摂取できる食品添加剤や製剤の研究も多くなされている。   Conventionally, in order to raise deep body temperature and improve immune function, exercise has been tried, massage and diet improvement, Chinese medicine intake, etc., but there are no side effects and food that can be easily taken orally Many studies on additives and preparations have also been made.

例えば、酢酸トコフェロール、高麗人参、生姜、カプサイシン(唐辛子エキス由来の化合物)等の血流促進剤が挙げられるが、これらは体表面温度を一時的に上昇させることはできるものの、深部体温の変調を正常化することはできないため、体温低下の根本的な解決とはならなかった。   For example, blood flow promoters such as tocopherol acetate, ginseng, ginger, capsaicin (a compound derived from chili extract) can be mentioned, but these can temporarily increase the body surface temperature, but do not modulate the deep body temperature. Since it cannot be normalized, it did not provide a fundamental solution to lowering body temperature.

そこで、特に深部体温の変調を正常化することを目的に、様々な植物から得られた抽出物を摂取する研究が行われてきた。例えば、松の樹皮から抽出されるプロアントシアニジン(特許文献1)、キヌア抽出物(特許文献2)、ハマウツボ科ホンオニク属植物の抽出物(特許文献3)などが検討されている。しかしながら、これらの働きは、いまだ十分なものとはいえなかった。   Thus, studies have been conducted on ingesting extracts obtained from various plants, with the aim of normalizing the modulation of deep body temperature. For example, proanthocyanidins extracted from pine bark (patent document 1), quinoa extract (patent document 2), extracts of the genus Hononiku (patent document 3) and the like have been studied. However, these functions were still not sufficient.

特開2006−143654号公報JP 2006-143654 A 特開2010−260848号公報JP 2010-260848 A 特開2011−157302号公報JP 2011-157302 A

本発明は、上記従来の事情に鑑みてなされたもので、その課題は、深部体温を上昇させる深部体温上昇剤を提供することにある。   This invention is made | formed in view of the said conventional situation, The subject is providing the deep body temperature raising agent which raises deep body temperature.

(1) 黒生姜加工物品を含有することを特徴とする深部体温上昇剤。   (1) A deep body temperature increasing agent characterized by containing a black ginger processed article.

(2)前記黒生姜加工物品が黒生姜の根茎を利用したものである(1)の深部体温上昇剤。   (2) The deep body temperature elevating agent according to (1), wherein the black ginger processed article uses a black ginger rhizome.

本発明によれば、顕著な深部体温の上昇作用を有するので、持続化する体温低下を誘引している深部体温の変調を正常化し、生体の体温を正常な状態に戻すことができる。また、本発明は、低血圧、内臓機能低下(便秘・下痢)、免疫力低下、血行不良(冷え・肩こり・腰痛・関節痛)、睡眠障害、新陳代謝低下(肥満)、うつ等の疾患であって、かつ、持続する低体温状態を原因とする疾患の治療や予防に用いることができる。 According to the present invention, since it has a remarkable effect of increasing the deep body temperature, it is possible to normalize the modulation of the deep body temperature that induces a sustained decrease in body temperature, and return the body temperature of the living body to a normal state. The present invention also relates to diseases such as hypotension, decreased visceral function (constipation / diarrhea), decreased immunity, poor circulation (coldness, stiff shoulders, low back pain, joint pain), sleep disorder, decreased metabolism (obesity), depression, etc. In addition, it can be used for treatment and prevention of diseases caused by persistent hypothermia.

マウスの耳内体温の経時変化を示す。The time-dependent change of the body temperature in the ear of a mouse | mouth is shown. マウスの耳内体温の曲線下面積を示す。The area under the curve of the intrabody temperature of the mouse is shown. マウスの表面体温の経時変化を示す。The time-dependent change of the surface body temperature of a mouse | mouth is shown. マウスの表面体温の曲線下面積を示す。The area under the curve of the surface temperature of the mouse is shown. マウスの褐色脂肪組織交感神経活動の経時変化を示す。The time-dependent change of the brown adipose tissue sympathetic nerve activity of a mouse | mouth is shown.

以下、本発明の実施形態について説明する。   Hereinafter, embodiments of the present invention will be described.

黒生姜(Kaempferia Parviflora)は東南アジアに自生するショウガ科、バンウコン属の植物で、精力増進、滋養強壮、血糖値の低下、体力回復、消化器系の改善、膣帯下、痔核、痔疾、むかつき、口内炎、関節痛、胃痛の改善などの報告がある。黒生姜は、長期にわたり人間に摂取されてきた実績のある天然植物である。本発明者らは、黒生姜の様々な生理作用を明らかにする中で、優れた深部体温上昇効果を有することを見出し、本発明を完成するに至った。   Kaempferia Parviflora is a plant belonging to the genus Gingidae, genus Van turmeric that grows naturally in Southeast Asia. It increases energy, nourishing tonicity, lowering blood sugar level, restoring physical strength, improving digestive system, vaginal zone, hemorrhoids, hemorrhoids, nausea, There are reports of improvement in stomatitis, joint pain, and stomach pain. Black ginger is a natural plant that has been ingested by humans for a long time. The present inventors have found that the various physiological actions of black ginger have an excellent deep body temperature increasing effect, and have completed the present invention.

体表面温度のみの上昇とは異なり、深部体温の上昇作用により、低血圧、内臓機能低下(便秘・下痢)、免疫力低下、血行不良(冷え・肩こり・腰痛・関節痛)、睡眠障害、新陳代謝低下(肥満)、うつ等の疾患であって、かつ、持続する低体温状態を原因とする疾患の治療や予防が可能となる。 Unlike elevated body surface temperature alone, deep body temperature increases, resulting in hypotension, decreased visceral function (constipation / diarrhea), decreased immunity, poor circulation (coldness, stiff shoulders, low back pain, joint pain), sleep disorders, metabolism It is possible to treat or prevent diseases such as depression (obesity), depression and the like caused by persistent hypothermia.

より具体的には、本発明は以下のようなものを提供する。   More specifically, the present invention provides the following.

本発明の組成物を得るための黒生姜の使用部位は樹皮、根、葉、茎、花または枝等が使用し得る。なかでも、好ましいのは、根茎である。具体的には、黒生姜の加工品(乾燥物、裁断物等)あるいはその粉末、絞り汁または抽出物を利用することができる。なお、ここで、抽出物とは、上記黒生姜またはその加工物を溶媒で抽出して得られる抽出液、その希釈液または濃縮液、あるいはそれらの乾燥物およびその粉末を意味する。食品または医薬品として使用する点などを考慮すると、抽出物を用いることも好ましい。本発明において、加工物品とは、これらのすべてを包含する。   Bark, roots, leaves, stems, flowers, branches, etc. can be used as black ginger for obtaining the composition of the present invention. Among them, preferred is a rhizome. Specifically, black ginger processed products (dried products, cut products, etc.) or powders, juices or extracts thereof can be used. Here, the extract means an extract obtained by extracting the black ginger or processed product thereof with a solvent, a diluted solution or a concentrated solution thereof, or a dried product thereof and a powder thereof. In consideration of the point of use as food or medicine, it is also preferable to use an extract. In the present invention, the processed article includes all of them.

黒生姜の粉末製品は、洗浄後、スライスした黒生姜を天日、あるいは乾燥機を用いて乾燥後、そのままあるいは適当な形状または大きさに裁断して得た加工品を、粉砕装置を用いて粉砕することで得ることができる。粉砕装置としては通常使用されるものがひろく使用できるが、例えば、原料ホッパー、粉砕機、分級機及び製品ホルダー等から構成される粉砕機を用いることができる。   Black ginger powder products are washed, dried sliced black ginger using the sun or a dryer, and then processed as it is or cut into an appropriate shape or size using a crusher. It can be obtained by grinding. As the pulverizer, those usually used can be widely used. For example, a pulverizer composed of a raw material hopper, a pulverizer, a classifier, a product holder and the like can be used.

黒生姜の抽出物は、黒生姜またはその加工物を溶媒で抽出することによって得られる。抽出に使用される溶媒としては、エタノール、メタノール、イソプロパノール、ブタノールなどの低級アルコール、酢酸エチル、酢酸メチルなどの低級エステル、アセトン、およびこれらと水との混合物が挙げられる。中でも、本発明の組成物は、ヒトが摂取するものであることから、エタノール単独または水との混合物(いわゆる含水エタノール)を使用するのが好ましい。特に、40%以上の濃度で、エタノールを含む溶媒を使用するのが好ましい。 An extract of black ginger is obtained by extracting black ginger or a processed product thereof with a solvent. Examples of the solvent used for extraction include lower alcohols such as ethanol, methanol, isopropanol and butanol, lower esters such as ethyl acetate and methyl acetate, acetone, and a mixture of these with water. Among these, since the composition of the present invention is ingested by humans, it is preferable to use ethanol alone or a mixture with water (so-called hydrous ethanol). In particular, it is preferable to use a solvent containing ethanol at a concentration of 40% or more.

溶媒として混合物を使用する場合は、例えば、アセトン/水(2/8〜8/2、体積比)混合物、エタノール/水(2/8〜8/2、体積比)混合物等を用いることができる。エタノール/水の場合、黒生姜の根茎に対して、その質量の2〜20倍質量の溶媒を加え、室温または加熱下で10分〜48時間抽出するのが好ましい。 When a mixture is used as the solvent, for example, an acetone / water (2/8 to 8/2, volume ratio) mixture, an ethanol / water (2/8 to 8/2, volume ratio) mixture, or the like can be used. . In the case of ethanol / water, it is preferable to add a solvent having a mass of 2 to 20 times its mass to the rhizome of black ginger and extract it at room temperature or under heating for 10 minutes to 48 hours.

用いる抽出方法に特に制限はないが、安全性および利便性の観点から、できるだけ緩やかな条件で行うことが好ましい。例えば、原料植物部位またはその乾燥物を粉砕、破砕または細断し、これに2〜20倍質量の溶媒を加え、0℃〜溶媒の還流温度の範囲で10分〜48時間、静置、振盪、撹拌あるいは還流などの任意の条件下にて抽出を行う。抽出作業後、濾過、遠心分離などの分離操作を行い、不溶物を除去する。これに、必要に応じて希釈、濃縮操作を行うことにより、抽出液を得る。さらに、不溶物についても同じ操作を繰り返して抽出し、その抽出液を先の抽出液と合わせて用いてもよい。これらの抽出物は、当業者が通常用いる精製方法により、さらに精製して使用してもよい。 There is no particular limitation on the extraction method to be used, but it is preferable that the extraction is performed under as mild conditions as possible from the viewpoint of safety and convenience. For example, the raw material plant part or its dried product is crushed, crushed or shredded, 2 to 20 times the mass of solvent is added thereto, and the mixture is allowed to stand and shake for 10 minutes to 48 hours in the range of 0 ° C. to the reflux temperature of the solvent. The extraction is performed under any conditions such as stirring or refluxing. After the extraction operation, separation operations such as filtration and centrifugation are performed to remove insoluble matters. An extract is obtained by diluting and concentrating as necessary. Further, the same operation may be repeated for insoluble matter, and the extract may be used in combination with the previous extract. These extracts may be used after further purification by a purification method commonly used by those skilled in the art.

本願発明の深部体温上昇剤は、上記した目的に応じ、非経口投与剤、経口投与剤等として、そのまま、あるいは、他の成分と混合して使用することができる。非経口投与剤としては、静脈内投与剤、筋肉内投与剤、皮下投与剤、経皮投与剤等が用いられる。皮下投与剤のひとつである、腹腔内投与剤としてもよい。また、経腸投与剤として、注射等を用い内臓へ直接投与することも好ましい。   The deep body temperature increasing agent of the present invention can be used as it is, or as a mixture with other components, as a parenteral administration agent, an oral administration agent or the like, according to the above-mentioned purpose. As parenteral administration agents, intravenous administration agents, intramuscular administration agents, subcutaneous administration agents, transdermal administration agents and the like are used. It is good also as an intraperitoneal administration agent which is one of the subcutaneous administration agents. Moreover, it is also preferable to administer directly to the internal organs by injection etc. as an enteral agent.

さらに、本願発明の深部体温上昇剤は、化粧品に適した形態として使用することもできる。例えば、ローション剤、乳剤、ゲル剤、クリーム剤、軟膏剤等の種々の形態に加工され得る。具体的には、化粧水、化粧クリーム、乳液、クリーム、パック、ヘアトニック、ヘアクリーム、シャンプー、ヘアリンス、トリートメント、ボディシャンプー、洗顔剤、石鹸、ファンデーション、育毛剤、水性軟膏、スプレー等として利用できる。   Furthermore, the deep body temperature increasing agent of this invention can also be used as a form suitable for cosmetics. For example, it can be processed into various forms such as lotions, emulsions, gels, creams, ointments and the like. Specifically, it can be used as lotion, cosmetic cream, milky lotion, cream, pack, hair tonic, hair cream, shampoo, hair rinse, treatment, body shampoo, facial cleanser, soap, foundation, hair restorer, aqueous ointment, spray, etc. .

黒生姜の成分の変性防止の観点からは非経口投与剤とする方法もあるが、黒生姜の成分は有機溶剤による抽出にも耐えられるほど丈夫で、胃液等への暴露によっても変性しにくいため、経口投与剤としても十分な効果を得ることができる。経口投与剤としては、例えば、錠剤、顆粒剤、散剤、カプセル等がある。カプセル化して、内臓にそのまま到達させる量を増やすことが好ましい。さらに、本発明の一剤は、錠剤、散剤、カプセル等の剤形状を有するもののほか、ドリンク剤、シロップ剤、ゼリーの形で供給され得る。   Although there is a method for parenteral administration from the viewpoint of preventing the degeneration of black ginger components, the components of black ginger are strong enough to withstand extraction with organic solvents and are not easily denatured by exposure to gastric juice. A sufficient effect can also be obtained as an oral administration agent. Examples of the orally administered agent include tablets, granules, powders, and capsules. It is preferable to encapsulate and increase the amount that reaches the internal organs as it is. Furthermore, one agent of the present invention can be supplied in the form of drinks, syrups, and jelly, in addition to those having dosage forms such as tablets, powders, and capsules.

経口投与剤としては、例えば、当業者が通常用いる添加剤(例えば、デキストリン、デンプン、糖類、リン酸カルシウムなどの賦形剤、香料、香油など)を用いて、錠剤、顆粒剤などの形状に成形してもよく、あるいは、水、飲料などに溶解して、液剤としてもよい。好ましくは、カプセル剤、顆粒剤、錠剤または飲料の形態である。   As an orally administered agent, for example, it is formed into a tablet, granule or the like using additives usually used by those skilled in the art (for example, excipients such as dextrin, starch, sugar, calcium phosphate, fragrance, perfume oil, etc.). Alternatively, it may be dissolved in water, beverage or the like to form a liquid. Preferably, it is in the form of a capsule, granule, tablet or beverage.

カプセル剤の製造方法としては、内容物として上記植物または抽出物を用いること以外は、従来公知のソフトカプセルの製造方法に従えばよい。そのような製造法としては、カプセル皮膜シートを用いて、ロータリー式充填機で内容物を封入し、カプセル製剤を成型する方法、または滴下法によりシームレスカプセルを製造する方法などが挙げられる。   As a method for producing capsules, a conventionally known method for producing soft capsules may be used except that the above plant or extract is used as the contents. Examples of such a production method include a method of encapsulating contents with a rotary filling machine using a capsule film sheet and molding a capsule preparation, or a method of producing a seamless capsule by a dropping method.

また、錠剤については、上記植物または抽出物を含有する顆粒あるいは抽出物そのものに、適切な結合剤、賦形剤、崩壊剤および必要に応じて滑沢剤を添加し、公知の打錠法により調製することができる。顆粒剤については、公知の各種湿式、乾式などの造粒法が適用でき、適切な結合剤および賦形剤とともに成形する。さらに、ドリンク剤、シロップ剤、ゼリー等については、適切な糖、酸、香料などを添加して香味を調整し、公知の製法により調製することができる。   For tablets, add appropriate binders, excipients, disintegrants and lubricants as necessary to the granules containing the plant or the extract or the extract itself, and use a known tableting method. Can be prepared. For the granule, various known wet and dry granulation methods can be applied, and the granule is molded together with an appropriate binder and excipient. Furthermore, drinks, syrups, jellies, etc. can be prepared by adding known sugars, acids, fragrances and the like to adjust the flavor and preparing them by known production methods.

本発明の深部体温上昇剤に含有される黒生姜加工物品の配合量としては特に制限はないが、経口投与剤であれば、好ましくは0.0001%以上、より好ましくは0.001%以上配合されることが望ましく、化粧品等の非経口投与剤であれば、好ましくは0.00001%以上、より好ましくは0.0001%以上配合されることが望ましい。   Although there is no restriction | limiting in particular as a compounding quantity of the black ginger processed article contained in the deep body temperature increasing agent of this invention, If it is an oral administration agent, Preferably it is 0.0001% or more, More preferably, it mix | blends 0.001% or more. In the case of a parenteral administration agent such as cosmetics, it is preferably 0.00001% or more, more preferably 0.0001% or more.

次に、本発明を実施例に基づいて更に詳細に説明するが、本発明はこれに限定されるものではない。 Next, the present invention will be described in more detail based on examples, but the present invention is not limited thereto.

(体温上昇効果の確認)
(1)被験物質
黒生姜は、タイ産黒生姜の根茎をミルサーで粗粉砕したものを使用した。生姜末は、中国産の褐色粉末をそのまま使用した。いずれも、投与の際、蒸留水を溶媒として、50mg/mLおよび100mg/mLとなるように懸濁して使用した。なお、エタノールは、蒸留水を溶媒として20(v/v)%の溶液を作製して使用した。
(Confirmation of temperature rise effect)
(1) Test substance The black ginger was obtained by roughly pulverizing the rhizome of Thai black ginger with a miller. For the ginger powder, brown powder from China was used as it was. In both cases, distilled water was used as a solvent at the time of administration, and suspended at 50 mg / mL and 100 mg / mL. Ethanol was used by preparing a 20 (v / v)% solution using distilled water as a solvent.

(2)実験動物及び飼育方法
7週齢のICR雄性マウスを6匹1群として5群用意し、5日以上の馴化期間をおいた後、実験に使用した。群分けは、試験直前に体重の平均値がほぼ均一となるようにして行った。また、試験中は被試験物質投与から、試験終了後まで絶食、絶水とした。
(2) Experimental animals and breeding method Five groups of 6 ICR male mice of 7 weeks old were prepared as a group, and used for the experiment after a habituation period of 5 days or more. The grouping was performed so that the average value of body weight was almost uniform immediately before the test. During the test, the test substance was administered and fasted until the end of the test.

(3)被験物質の投与
ICR雄性マウスの1群をコントロール(蒸留水)とした。2、3群は黒生姜末投与群とし、2群に対しては黒生姜末を500g/kgあたり、同じく3群に対しては黒生姜末を1000mg/kgの各用量で1回経口投与した。また、4、5群は生姜末投与群とし、4群に対しては生姜末を500g/kgあたり、同じく5群に対しては生姜末を1000mg/kgの各用量で1回経口投与した。表1に、各試験群と投与量を示す。なお、被験物質およびエタノールは、それぞれマウスに10mL/kgで胃ゾンデにより強制経口投与を行った。
(3) Administration of test substance One group of ICR male mice was used as a control (distilled water). Groups 2 and 3 were administered with black ginger powder, and for group 2, black ginger powder was orally administered at a dose of 1000 mg / kg once per 500 g / kg. Also, groups 4 and 5 were ginger powder administration groups, and ginger powder was orally administered once per 500 g / kg for group 4, and ginger powder was once administered at 1000 mg / kg for group 5. Table 1 shows each test group and dose. Note that the test substance and ethanol were each forcibly orally administered to a mouse at 10 mL / kg with a stomach tube.

Figure 0006064156
Figure 0006064156

(4)体温測定
被試験物質をマウスに投与後5分後に、エタノールを4000mg/kgで腹腔内投与した。試験開始前(0分)及び投与直後(5分)に各部体温を測定し、その後は開始10分後から10分毎に60分までの体温を測定した。マウスの体温測定には、動物用耳内体温計Pet−Temp(PT−300;Advanced Monitors
Corporation)を使用し、耳内および表面(背部)体温を測定した。
(4) Body temperature measurement Five minutes after administration of the test substance to the mice, ethanol was intraperitoneally administered at 4000 mg / kg. The body temperature of each part was measured before the start of the test (0 minutes) and immediately after administration (5 minutes), and thereafter the body temperature was measured every 10 minutes up to 60 minutes after the start of 10 minutes. For measuring the body temperature of mice, an animal ear thermometer Pet-Temp (PT-300; Advanced Monitors)
Corporation was used to measure in-ear and surface (back) body temperature.

(5)結果
図1にマウスの耳内で測定した体温の径時変化、図2に得られた体温変化曲線の面積(AUC)を示す。また、図3にマウスの体表面で測定した体温の径時変化、図4に得られた体温変化曲線の面積(AUC)を示す。
(5) Results FIG. 1 shows the time-dependent changes in body temperature measured in the ear of the mouse, and FIG. 2 shows the area (AUC) of the body temperature change curve obtained. FIG. 3 shows changes in body temperature measured on the body surface of the mouse, and FIG. 4 shows the area (AUC) of the body temperature change curve obtained.

エタノールの投与は、マウスの耳内および表面の体温を低下させる。表面温度に関して、黒生姜および生姜の投与は、ともに体温低下を抑制する作用はほとんどみられない。しかしながら、耳内温度については、生姜を投与した場合(第4,5群)は体温が低下したが、黒生姜においては、生姜とは逆に、強い低下抑制作用を示し、また、その作用は長く持続した(第2,3群)。   Administration of ethanol reduces the body temperature in the ear and surface of the mouse. Regarding the surface temperature, the administration of ginger and ginger has little effect on suppressing the decrease in body temperature. However, with regard to the temperature in the ear, when ginger was administered (Groups 4 and 5), the body temperature decreased, but in black ginger, contrary to ginger, it showed a strong decrease-inhibiting action, and its action was Long lasting (Group 2, 3).

以上の結果から、黒生姜の摂取が深部体温を上昇させ得ることを確認することができた。一方、抹消の血管を拡張することで知られる生姜には、そのような効果は極めて低いか、あるいはないものと考えられる。   From the above results, it was confirmed that the intake of black ginger can increase the deep body temperature. On the other hand, ginger known to dilate peripheral blood vessels is considered to have very little or no such effect.

(体温上昇原因の検討)
(黒生姜抽出液の製造)
黒生姜の根茎チップ300gを秤量し、60%エタノール3lとともに3角フラスコに入れる。途中で何回か攪拌しながら室温で24時間静置する。減圧濾過後、残ったチップに60%エタノール3lに再度浸漬して、室温で24時間静置して抽出を行う。これを減圧濾過して、2回目の抽出液を得た。前記1回目、2回目の抽出液を併せ、これを約1/6に減圧濃縮して原液とした。
(Examination of cause of temperature rise)
(Manufacture of black ginger extract)
300 g of black ginger rhizome chips are weighed and placed in a triangular flask together with 3 l of 60% ethanol. Allow to stand at room temperature for 24 hours while stirring several times along the way. After filtration under reduced pressure, the remaining chip is dipped again in 3 l of 60% ethanol and left to stand at room temperature for 24 hours for extraction. This was filtered under reduced pressure to obtain a second extract. The first and second extracts were combined and concentrated under reduced pressure to about 1/6 to obtain a stock solution.

(褐色脂肪細胞組織活動評価試験)
12時間毎の明暗周期(8時〜20時まで点灯)下に24℃の恒温動物室にて1週間以上飼育した体重約300gのWistar系雄ラット(約9週齢)を使用した。実験当日は3時間絶食させた後ウレタン麻酔し、十二指腸投与用のカニューレを挿入し、その後、肩甲間褐色脂肪組織交感神経、大腿皮膚動脈交感神経の遠心枝を銀電極で吊り上げ、それら神経の電気活動を測定した。これらの測定値が落ち着いた時期(13時頃)に前記黒生姜抽出液を60%エタノールで500mg/kg投与量になるように溶解した原液を60%エタノールで100倍に希釈した液1mlを十二指腸に投与してこれらの自律神経活動の変化を電気生理学的に測定した。なお、対照実験としては溶媒である60%エタノール溶液1mlを十二指腸投与した。尚、手術開始から測定終了までチューブを気管に挿入して気道を確保し、保温装置にて体温(ラット直腸温)を35.0±0.5℃に保つようにした。自律神経活動のデータは5分間毎の5秒あたりの発火頻度(pulse/5s)の平均値にて解析し、刺激開始前の値(0分値)を100%とした百分率で表した。
(Brown adipocyte tissue activity evaluation test)
Wistar male rats (about 9 weeks old) having a body weight of about 300 g and kept in a constant temperature animal room at 24 ° C. for 1 week or more under a light / dark cycle every 12 hours (lighted from 8:00 to 20:00) were used. On the day of the experiment, after fasting for 3 hours, anesthetized with urethane, inserted a cannula for duodenal administration, then suspended the interscapular brown adipose tissue sympathetic nerve and the femoral cutaneous sympathetic nerve with a silver electrode, Electrical activity was measured. At the time when these measured values settled (around 13:00), 1 ml of a solution obtained by diluting the black ginger extract with 60% ethanol to a dose of 500 mg / kg was diluted 100 times with 60% ethanol. These changes in autonomic nervous activity were measured electrophysiologically. As a control experiment, 1 ml of a 60% ethanol solution as a solvent was administered into the duodenum. A tube was inserted into the trachea from the start of surgery to the end of measurement to secure the airway, and the body temperature (rat rectal temperature) was maintained at 35.0 ± 0.5 ° C. with a heat retaining device. The data of autonomic nerve activity was analyzed by the average value of the firing frequency per 5 seconds (pulse / 5s) every 5 minutes, and expressed as a percentage with the value before the start of stimulation (0 minute value) as 100%.

図5にマウスの肩甲間褐色脂肪組織交感神経活動(BAT−SNA)の経時変化を示す。対照実験として行なった60%エタノール溶液1mlの十二指腸投与は最初徐々にBAT−SNAを低下させ、投与25分後にBAT−SNAを最低値74.4%に減少させ、その後徐々にBAT−SNAを上昇させて投与60分後にはBAT−SNAを101.7%にまで回復させた。これに対して、原液の100倍希釈液(5mg/kg相当を含む)1mlの十二指腸投与は、BAT−SNAを最初やや低下させて投与15分後にはBAT−SNAを70.2%にまで減少させたが、その後BAT−SNAを徐々に著明に上昇させて、投与60分後には176.7%にまで増加させた。   FIG. 5 shows the time course of interscapular brown adipose tissue sympathetic nerve activity (BAT-SNA) in mice. The duodenal administration of 1 ml of a 60% ethanol solution performed as a control experiment first gradually decreased BAT-SNA, decreased BAT-SNA to the lowest value of 74.4% 25 minutes after administration, and then gradually increased BAT-SNA. In 60 minutes after the administration, BAT-SNA was recovered to 101.7%. In contrast, the duodenal administration of 1 ml of a 100-fold diluted solution of the stock solution (including 5 mg / kg equivalent) reduced BAT-SNA to 70.2% 15 minutes after administration. However, BAT-SNA was gradually increased gradually and increased to 176.7% 60 minutes after administration.

以上の実験結果より、黒生姜の抽出物の十二指腸投与が、対照実験として行なった60%エタノール溶液投与時と比較して、肩甲間褐色脂肪組織の活動を増加させて深部体温を上昇させることがわかった。   From the above experimental results, the duodenum administration of the black ginger extract increases the activity of interscapular brown adipose tissue and raises the deep body temperature compared with the 60% ethanol solution administration as a control experiment I understood.

さらに、上記の方法で得た黒生姜抽出液を乾燥した黒生姜エキス粉末、黒生姜粉砕物、および黒生姜抽出液を用い、下記表の処方で飲料、顆粒、ソフトカプセル、美容液、シャンプー、石鹸を作成した。
(黒生姜粉砕物の製造)
黒生姜の根茎を洗浄後、1〜10mm程度にスライスし、1日天日干しにした。その後、40〜100℃に設定したオーブン乾燥機で4〜6時間乾燥し、粗粉砕後、130〜200℃で5〜20秒間殺菌を行った。殺菌した粗粉砕物を粉砕機によって粉砕し、黒生姜粉砕物を得た。
(黒生姜の茎、葉、花粉砕物の製造)
上記と同様の方法により、黒生姜の茎粉砕物、葉粉砕物、花粉砕物を得た。
Furthermore, using the black ginger extract powder, the black ginger pulverized product, and the black ginger extract obtained by drying the black ginger extract obtained by the above method, beverages, granules, soft capsules, cosmetic liquids, shampoos, soaps are formulated according to the following table. It was created.
(Manufacture of crushed black ginger)
After washing the black ginger rhizome, it was sliced to about 1 to 10 mm and dried in the sun for one day. Then, it dried for 4 to 6 hours with the oven dryer set to 40-100 degreeC, and sterilized at 130-200 degreeC for 5 to 20 second after coarse grinding. The sterilized coarsely pulverized product was pulverized by a pulverizer to obtain a black ginger pulverized product.
(Manufacture of black ginger stems, leaves, and pulverized flowers)
By the same method as above, a black ginger stem pulverized product, a leaf pulverized product, and a flower pulverized product were obtained.

実施例1(液剤の製造)
表2の配合割合で各成分を配合し、液剤とした。
Example 1 (Manufacture of a liquid agent)
Each component was blended at the blending ratio in Table 2 to obtain a liquid.

Figure 0006064156
Figure 0006064156

実施例2(顆粒1の製造)
表3に従い、スクラロース0.5kg、クエン酸5kg、還元麦芽糖水飴64.5kg、難消化性デキストリン67.2kg、カンゾウ抽出物0.5kg、黒生姜粉砕物16.8kg,シクロデキストリン8.4kg、ショウヤク5kgをフローコーターNFLO−200型流動層造粒機(フロイント産業(株)製)に投入し、数分間気流で混合する。これに、水60Lを1分間に2000mL噴霧することにより造粒を行った。つづいて、得られた造粒物を30メッシュの篩いにて篩別し顆粒剤とした。
Example 2 (Production of granules 1)
According to Table 3, sucralose 0.5 kg, citric acid 5 kg, reduced maltose starch syrup 64.5 kg, indigestible dextrin 67.2 kg, licorice extract 0.5 kg, black ginger ground product 16.8 kg, cyclodextrin 8.4 kg, shoyaku 5 kg is charged into a flow coater NFLO-200 fluidized bed granulator (manufactured by Freund Sangyo Co., Ltd.) and mixed with an air stream for several minutes. This was granulated by spraying 2000 mL of water for 1 minute. Subsequently, the obtained granulated product was sieved with a 30-mesh sieve to obtain granules.

Figure 0006064156
Figure 0006064156

実施例3(顆粒2の製造)
実施例2と同様にして、表4の成分を配合し顆粒剤とした。
Example 3 (Production of granules 2)
In the same manner as in Example 2, the ingredients shown in Table 4 were blended to prepare granules.

Figure 0006064156
Figure 0006064156

実施例4(ソフトカプセル1の製造)
表5の配合割合で配合した内容液を調整し、表6の配合割合で配合したカプセル皮膜に充填することでソフトカプセルとした。カプセル化は、カプセル皮膜液を流延しフィルム化すると共に、内部に内容液を充填しヒートシールし、成形されたソフトカプセルを乾燥させて行った。
Example 4 (Production of soft capsule 1)
The content liquid blended at the blending ratio shown in Table 5 was prepared, and the capsule film blended at the blending ratio shown in Table 6 was filled into soft capsules. Encapsulation was performed by casting a capsule coating solution to form a film, filling the content solution inside, heat-sealing, and drying the formed soft capsule.

Figure 0006064156
Figure 0006064156

Figure 0006064156
Figure 0006064156

実施例5(ソフトカプセル2の製造)
表7の配合割合で配合した内容液を調整し、表8の配合割合で配合したカプセル皮膜に充填し、実施例4と同様にしてソフトカプセルとした。
Example 5 (Production of soft capsule 2)
The content liquid blended at the blending ratio shown in Table 7 was prepared, and the capsule film blended at the blending ratio shown in Table 8 was filled into soft capsules as in Example 4.

Figure 0006064156
Figure 0006064156

Figure 0006064156
Figure 0006064156

実施例6(美容液の製造)
表9の配合割合で各成分を配合し、美容液とした。
Example 6 (Manufacture of serum)
Each component was blended at the blending ratios shown in Table 9 to obtain a cosmetic liquid.

Figure 0006064156
Figure 0006064156

実施例7(シャンプーの製造)
表10の配合割合で各成分を配合し、シャンプーとした。
Example 7 (Production of shampoo)
Each component was mix | blended with the mixture ratio of Table 10, and it was set as the shampoo.

Figure 0006064156
Figure 0006064156

実施例8(石鹸の製造)
表11の配合割合で各成分を配合し、石鹸とした。
Example 8 (Manufacture of soap)
Each component was blended at a blending ratio shown in Table 11 to obtain a soap.

Figure 0006064156
Figure 0006064156

Claims (1)

黒生姜加工物品を含有し、前記黒生姜加工物品が黒生姜の根茎のエタノール抽出物を含有し、前記エタノール抽出物は、エタノール単独又は含水エタノールによる抽出物であることを特徴とする深部体温上昇剤。 A processed body of black ginger, the processed body of black ginger contains an ethanol extract of black ginger rhizome , and the ethanol extract is an extract of ethanol alone or water-containing ethanol. Agent.
JP2012154967A 2012-07-10 2012-07-10 Deep body temperature raising agent Active JP6064156B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012154967A JP6064156B2 (en) 2012-07-10 2012-07-10 Deep body temperature raising agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012154967A JP6064156B2 (en) 2012-07-10 2012-07-10 Deep body temperature raising agent

Publications (2)

Publication Number Publication Date
JP2014015430A JP2014015430A (en) 2014-01-30
JP6064156B2 true JP6064156B2 (en) 2017-01-25

Family

ID=50110457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012154967A Active JP6064156B2 (en) 2012-07-10 2012-07-10 Deep body temperature raising agent

Country Status (1)

Country Link
JP (1) JP6064156B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2511704B (en) * 2012-12-28 2018-10-24 Intel Corp Method, apparatus and system for providing metering of acceleration

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5845526B2 (en) * 2014-05-14 2016-01-20 株式会社東洋新薬 Water-soluble composition containing black ginger
JP5849272B1 (en) * 2014-09-10 2016-01-27 株式会社東洋新薬 Composition for promoting PPARγ expression containing black ginger
JP6710408B2 (en) * 2015-03-27 2020-06-17 株式会社東洋新薬 Composition containing black ginger extract
JP6541061B2 (en) * 2015-04-30 2019-07-10 株式会社東洋新薬 Composition for promoting clock gene expression
JP6447972B2 (en) * 2015-05-07 2019-01-09 株式会社東洋新薬 Composition for promoting PPARγ expression containing black ginger
JP6584270B2 (en) * 2015-10-09 2019-10-02 株式会社東洋新薬 Blood flow improving composition
JP2017088616A (en) * 2017-02-09 2017-05-25 株式会社東洋新薬 Kaempferia parviflora-containing compositions
JP6792715B2 (en) * 2017-08-30 2020-11-25 森永乳業株式会社 Composition for increasing core body temperature
JP6999907B2 (en) * 2019-03-29 2022-02-10 株式会社東洋新薬 Composition for promoting clock gene expression
US20210030830A1 (en) * 2019-07-31 2021-02-04 Tokiwa Phytochemical Co., Ltd. Composition for improving quantity of tear fluid, composition for improving constipation, and composition for improving skin quality

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000144170A (en) * 1998-09-01 2000-05-26 Janifu Tekku:Kk Substance having antiobestic function and action to reduce fat accumulated in internal organs and its use
JP2009067731A (en) * 2007-09-14 2009-04-02 Office K:Kk Composition for improving cold constitution
WO2009151541A1 (en) * 2008-05-27 2009-12-17 Boss Olivier D Brown adipocyte progenitors in human skeletal muscle

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2511704B (en) * 2012-12-28 2018-10-24 Intel Corp Method, apparatus and system for providing metering of acceleration

Also Published As

Publication number Publication date
JP2014015430A (en) 2014-01-30

Similar Documents

Publication Publication Date Title
JP6064156B2 (en) Deep body temperature raising agent
KR101853902B1 (en) Composition for improving skin wrinkle and enhancing elasticity
JP6211500B2 (en) Brown adipocyte activator
KR101989407B1 (en) A composition for promoting melanin synthesis comprising Cirsium japonicum extract
KR100999870B1 (en) Pharmaceutical composition for the prevention and treatment of allergic skin diseases containing extract of Houttuynia Cordata Thub and Ulmus davidana var.Japonica as an active ingredient
JP2016160198A (en) Kaempferia parviflora-containing compositions
KR20150057333A (en) Composition comprising extract of korean fir for preventing and improving obesity
EP4205558A1 (en) Health functional food, comprising siberian chrysanthemum extract, for pain relief or antioxidation
JPH09208484A (en) Active oxygen-eliminator and composition containing the same
JP6369931B2 (en) Anti-obesity agent
KR20220112888A (en) Functional collagen composition using collagen amino acid derived from Aurea Helianthus
JP6765090B2 (en) Black ginger-containing composition
KR20210002037A (en) A composition for preventing, improving or treating pain comprising olive leaf and citrus pericarp extract
KR101910013B1 (en) A composition for improving, preventing and treating of pain comprising herb extract
JP6541061B2 (en) Composition for promoting clock gene expression
KR101579500B1 (en) Skin whitening composition comprising an extract obtained from roots of coix lachryma-jobi var. mayuen
KR101897720B1 (en) Cosmetic or pharmaceutical composition for promoting hair growth comprising Tenebrio molitor fractions
KR20160082958A (en) Pharmaceutical composition for preventing or treating allergic diseases comprising extrat of Pterocarpus indicus Willd as an active ingredient
KR20110019977A (en) Composition for protection and treatment of stress and panic disorder
JP2010180141A (en) Anti-allergic composition
KR20160091593A (en) Pharmaceutical composition comprising Cymbidium extracts or its salts for preventing or treating allergic diseases or contact dermatitis
KR20190126565A (en) A composition for improving, preventing and treating of pain containing oriental medicine herbs oil extract as an active ingredient
JP2019094357A (en) Clock gene expression promoting composition
CN113181205B (en) Pharmaceutical composition comprising NMN and use thereof
KR20150051710A (en) Pharmaceutical composition for preventing or treating allergic diseases comprising extrat of Pterocarpus indicus Willd as an active ingredient

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150326

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160308

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160506

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160629

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161004

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161007

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20161108

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20161117

R150 Certificate of patent or registration of utility model

Ref document number: 6064156

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250